Intercept Pharmaceuticals, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
22.79
|
|
Average Rating
|
3.31
|
|
# Strong Buys
|
2
|
|
# Buys
|
3
|
|
# Holds
|
9
|
|
# Sells
|
2
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
4.61
|
7.80
|
3.19
|
69.20%
|
|
2022-06-30
|
-0.49
|
-0.25
|
0.24
|
48.98%
|
|
2022-03-31
|
-0.90
|
-0.58
|
0.32
|
35.56%
|
|
2021-12-31
|
-1.10
|
-1.23
|
-0.13
|
-11.82%
|
|
2021-09-30
|
-1.09
|
-0.11
|
0.98
|
89.91%
|
|
2021-06-30
|
-1.22
|
-0.33
|
0.89
|
72.95%
|
|
2021-03-31
|
-1.44
|
-1.22
|
0.22
|
15.28%
|
|
2020-12-31
|
-1.47
|
-1.58
|
-0.11
|
-7.48%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
6.97
|
|
2021-12-31
|
-2.89
|
|
2020-12-31
|
-8.37
|
|
2019-12-31
|
-10.89
|
|
2018-12-31
|
-10.95
|
|
2017-12-31
|
-14.39
|
|
2016-12-31
|
-16.74
|
|
2015-12-31
|
-9.49
|
|
2014-12-31
|
-3.40
|
|
2013-12-31
|
-3.70
|
|
2012-12-31
|
-3.88
|